Presentation TCT 2018 Spain Presents: Hemodynamic Support in a Killip IV Class Patient With Acute Myocardial Infarction Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Nezihi Baris, Rik Hermanides, Raul Moreno, Mark W.I. Webster September 23, 2018
Presentation TCT 2018 Introduction Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen September 23, 2018
Presentation TCT 2018 CvLPRIT: Long-term Follow-up From a Randomized Trial of Early Complete Revascularization in Patients With Acute Myocardial Infarction and Multivessel Disease Presenter: Jonathan M. Hill, E. Magnus Ohman, Anthony H. Gershlick September 22, 2018
Presentation TCT 2018 AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device Presenter: Jonathan M. Hill, E. Magnus Ohman, William W. O'Neill September 22, 2018
Presentation TCT 2018 TCT-52: Intravascular Imaging-guided Urgent Percutaneous Coronary Intervention for Acute Myocardial Infarction and Long-term (3 years) Prognosis: A Land Mark Analysis of J-MINUET Presenter: David A. Cox, Dariusz Dudek, Hiroyuki Okura September 21, 2018
Presentation TCT 2018 TCT-82: Race-based Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Study Presenter: Biswajit Kar, Simon Redwood, Saraschandra Vallabhajosyula September 21, 2018
Presentation TCT 2018 Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study Presenter: Ulrich P. Jorde, John M. Lasala, Christoph Garlichs September 21, 2018
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
Presentation TCT 2017 TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients Presenter: Patrick W. Serruys, Konstantinos Voudris November 01, 2017
Presentation TCT 2017 Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials Presenter: Bernard J. Gersh, Michel Ovize October 31, 2017
Presentation TCT 2017 CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles October 31, 2017
Presentation TCT 2017 Trials With Cardiac Derived Cells: CAREMI and ALLSTAR Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz October 31, 2017
Presentation TCT 2017 US Trial Background and Update: Preserve-AMI Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry October 31, 2017
Presentation TCT 2017 The Clinical Point of View: Is There an AMI Need for Cell Therapy? Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez October 31, 2017
Presentation TCT 2017 CASE 2- Image Guided Intervention in Traumatic Dissection of Dominant Right Coronary Artery Presenting as Acute Myocardial Infarction Presenter: Pedro de Araujo Goncalves, Rabin dra Nath Chakraborty October 30, 2017
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
Presentation TCT 2016 TCT 1129: Safety and Efficacy of Percutaneous Implantable Right Ventricular Assist Device for Management of Right Ventricular Failure Secondary to Acute Inferior Myocardial Infarction Presenter: Maurice Buchbinder, Marco A. Costa, Abhishek Sawant October 30, 2016
Presentation TCT 2016 TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016